Barinthus Biotherapeutics's total assets for Q2 2025 were $129.56M, a decrease of -8.76% from the previous quarter. BRNS total liabilities were $27.08M for the fiscal quarter, a 2.56% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.